Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jove

Showing results (271-280 of 517) with videos related to

Pageof 52
Sort By:
The Journal of Biological Chemistry|February 14, 1997
The hsp90-binding antibiotic geldanamycin decreases Raf levels and epidermal growth factor signaling without disrupting formation of signaling complexes or reducing the specific enzymatic activity of Raf kinaseL F Stancato, A M Silverstein, J K Owens-Grillo, et al.
Cancers|September 15, 2020
Synergistic Anti-Tumor Activity by Targeting Multiple Signaling Pathways in Ovarian CancerWei Wen, Ernest S Han, Thanh H Dellinger, et al.
Anales Espanoles De Pediatria|October 1, 1992
[Ingestion of alkaline batteries: a better alternative for their extraction]D Gutiérrez Bethancourt, V Varea Calderón, R Aguilar Téllez, et al.
Journal of the American Chemical Society|March 5, 2013
General approach for preparing epidithiodioxopiperazines from trioxopiperazine precursors: enantioselective total syntheses of (+)- and (-)-gliocladine C, (+)-leptosin D, (+)-T988C, (+)-bionectin A, and (+)-gliocladin AJohn E DeLorbe, David Horne, Richard Jove, et al.
Cellular Signalling|January 5, 2000
The Src-family kinase Lck can induce STAT3 phosphorylation and DNA binding activityT C Lund, C Coleman, E Horvath, et al.
Cancer Research|April 20, 2001
Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrestG Niu, K H Shain, M Huang, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|January 7, 1998
Overexpression of normal c-Src in poorly metastatic human colon cancer cells enhances primary tumor growth but not metastatic potentialR Irby, W Mao, D Coppola, et al.
The Journal of Biological Chemistry|February 15, 1992
Reconstitution of the multiprotein complex of pp60src, hsp90, and p50 in a cell-free systemK A Hutchison, B K Brott, J H De Leon, et al.
Human Pathology|November 11, 2003
Modification of insulin-like growth factor 1 receptor, c-Src, and Bcl-XL protein expression during the progression of Barrett's neoplasiaShohreh Iravani, Hong Q Zhang, Zeng Q Yuan, et al.
Molecular Cancer Research : MCR|August 19, 2007
Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicityRalf Buettner, Mei Huang, Tanya Gritsko, et al.
Pageof 52

Showing results (271-280 of 517) with videos related to

Sort By:
Pageof 52
The Journal of Biological Chemistry|February 14, 1997
The hsp90-binding antibiotic geldanamycin decreases Raf levels and epidermal growth factor signaling without disrupting formation of signaling complexes or reducing the specific enzymatic activity of Raf kinaseL F Stancato, A M Silverstein, J K Owens-Grillo, et al.
Cancers|September 15, 2020
Synergistic Anti-Tumor Activity by Targeting Multiple Signaling Pathways in Ovarian CancerWei Wen, Ernest S Han, Thanh H Dellinger, et al.
Anales Espanoles De Pediatria|October 1, 1992
[Ingestion of alkaline batteries: a better alternative for their extraction]D Gutiérrez Bethancourt, V Varea Calderón, R Aguilar Téllez, et al.
Journal of the American Chemical Society|March 5, 2013
General approach for preparing epidithiodioxopiperazines from trioxopiperazine precursors: enantioselective total syntheses of (+)- and (-)-gliocladine C, (+)-leptosin D, (+)-T988C, (+)-bionectin A, and (+)-gliocladin AJohn E DeLorbe, David Horne, Richard Jove, et al.
Cellular Signalling|January 5, 2000
The Src-family kinase Lck can induce STAT3 phosphorylation and DNA binding activityT C Lund, C Coleman, E Horvath, et al.
Cancer Research|April 20, 2001
Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrestG Niu, K H Shain, M Huang, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|January 7, 1998
Overexpression of normal c-Src in poorly metastatic human colon cancer cells enhances primary tumor growth but not metastatic potentialR Irby, W Mao, D Coppola, et al.
The Journal of Biological Chemistry|February 15, 1992
Reconstitution of the multiprotein complex of pp60src, hsp90, and p50 in a cell-free systemK A Hutchison, B K Brott, J H De Leon, et al.
Human Pathology|November 11, 2003
Modification of insulin-like growth factor 1 receptor, c-Src, and Bcl-XL protein expression during the progression of Barrett's neoplasiaShohreh Iravani, Hong Q Zhang, Zeng Q Yuan, et al.
Molecular Cancer Research : MCR|August 19, 2007
Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicityRalf Buettner, Mei Huang, Tanya Gritsko, et al.
Pageof 52